Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey
Jean C. Vélez Rodríguez, Yanice Duquesne-Maldonado, Julián M. Hernández Torres, Istoni Da'Luz Sant'Ana, Cruz M. Nazario
Journal of Psychedelic Studies April 15, 2026 DOI: 10.1556/2054.2026.00519 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 343 |
| Population | Adults residing in Puerto Rico recruited through internet-based advertisements |
| Topics | Psilocybin |
| Key findings | In a convenience sample, 52.6% reported lifetime psilocybin use; significant explanatory factors included male sex, bisexual or non-heterosexual identity, non-Christian affiliation, openness, and agreeableness, while gay identity was associated with lower odds. |
Abstract
Abstract Background and aims Psilocybin, a psychoactive compound found in fungi commonly referred to as “magic mushrooms,” is consumed for both spiritual and recreational purposes. However, psilocybin use in Puerto Rico remains understudied. This exploratory cross-sectional survey aimed to describe patterns of use, motivations for consumption, explanatory factors, personality traits, and sex-gender differences associated with psilocybin use in a convenience sample of adults residing in Puerto Rico.
Methods: The study recruited 343 respondents through internet-based advertisements to complete an online survey, which included demographic variables, patterns of psilocybin consumption, polysubstance use and the Ten-Item Personality Inventory (TIPI-SPA). Logistic regression models were used to identify significant explanatory factors.
Results: Within this convenience sample, 52.6% of participants reported lifetime psilocybin use; this figure reflects the recruited sample and should not be interpreted as a population prevalence estimate. Participants largely believed that magic mushrooms were non-addictive (61%) and safe (57%). Curiosity was the primary motivation for use (43%), and most participants reported pleasant or very pleasant experiences (88%). Significant explanatory factors of psilocybin consumption included identifying as male (adjusted odds ratio [aOR] = 6.2; 95% CI: 2.81–14.49), identifying as bisexual (aOR = 3.14; 95% CI: 1.14–9.14), identifying as gay (aOR = 0.14; 95% CI: 0.03–0.54), identifying as non-heterosexual identities (aOR = 4.33; 95% CI: 1.27–16.38), identifying as non-Christian (aOR = 3.76; 95% CI: 1.77–8.37), openness (aOR = 2.09; 95% CI: 1.49–3.0) and agreeableness (aOR = 1.75; 95% CI: 1.20–2.63).
Conclusion: This exploratory study describes psilocybin use in a convenience sample of adults in Puerto Rico by sociodemographic characteristics, patterns of consumption, sex-gender identity, and personality traits. Findings are preliminary and warrant replication using probability-based sampling designs.
Comparable studies
Other cross-sectional and survey studies on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Individuals who had consumed psilocybin mushrooms and experienced a psychologically... | 2016 | Cross-sectional survey | n = 1,993 |
| The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms Internet survey respondents reporting challenging experiences with psilocybin | 2016 | Questionnaire development and validation | |
| Psychedelics and Mental Health: A Population Study Adult population in the United States | 2013 | Cross-sectional survey | n = 130,152 |
| Cessation and reduction in alcohol consumption and misuse after psychedelic use Individuals with prior alcohol use disorder who reported cessation or reduction in... | 2019 | Cross-sectional survey | n = 343 |
| Patterns of simultaneous polysubstance use in drug using university students Drug-using university students | 2006 | Cross-sectional survey | n = 149 |
Citations in the library
Cites 21
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Journal of Psychopharmacology September 11, 2014
and 16 more in the library